SLC4A1 and ablepharon macrostomia syndrome: Furthermore, S100A12, SLC4A1, IGFBP7, APOB, A-TPO, phosphate, and cholesterol were correlated with multiple symptom phenotypes, such as fatigue, nausea, vomiting, and poor appetite (C2 in Fig. 5), which indicates their potential important roles in the development of AMS.